Leptin treatment ameliorates anxiety in ob/ob obese mice

By Asakawa A.   Inui A.   Inui T.   Katsuura G.   Fujino M.A.   Kasuga M.  

Journal of Diabetes and its Complications, Vol. 17, Iss. 2, 2003-03 ,pp. : 105-107

Elsevier

Access to resources Recommend Favorite

Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro³)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice

By Irwin N.   McClean P.   O’Harte F.   Gault V.   Harriott P.   Flatt P.  

Diabetologia, Vol. 50, Iss. 7, 2007-07 ,pp. : 1532-1540

Springer Publishing Company

Access to resources Recommend Favorite

Effects of leptin, acetylcholine and vasoactive intestinal polypeptide on insulin secretion in isolated ob/ob mouse pancreatic islets

By Persson-Sjögren S.   Elmi A.   Lindström P.  

Acta Diabetologica, Vol. 41, Iss. 3, 2004-09 ,pp. : 104-112

Springer Publishing Company

Access to resources Recommend Favorite

Human Obesity: Its Hormonal Basis and the Role of Gastric Inhibitory Polypeptide

By  

Medical Principles and Practice, Vol. 15, Iss. 5, 2006-08 ,pp. : 325-337

Karger

Access to resources Recommend Favorite

Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets

By Gault V.   McClean P.   Cassidy R.   Irwin N.   Flatt P.  

Diabetologia, Vol. 50, Iss. 8, 2007-08 ,pp. : 1752-1762

Springer Publishing Company

Access to resources Recommend Favorite